Serum and CSF NfH levels are elevated both in MS patients and in EAE mice, and higher plasma/serum NfH levels were described in acute optic neuritis with higher levels predicting a worse visual outcome [23]. This evidence concerns the gene NEFH and myeloid sarcoma.